20 May 2013
Keywords: Memantine, Merz, Donepezil, Alzheimer's disease, ChEI, Combination treatment
Article | 13 September 2011
New data showing that combination therapy with a cholinesterase inhibitor (ChEI) and memantine (Axura, from Germany’s Merz) - ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 September 2011
17 May 2013
© 2013 thepharmaletter.com